Target intelligence / Profile preview

RNA, U6 small nuclear 241, pseudogene (RNU6-241P)

Target
RNU6-241P
Molecular classification
Other (Pseudogene, non-coding RNA pseudogene)
01

Overview

RNU6-241P encodes a **pseudogene** of the U6 small nuclear RNA, which is an essential non-coding RNA component of the spliceosome complex responsible for the removal of introns from pre-mRNA during splicing[1]. The parental U6 snRNA is highly conserved and performs a critical function in the nucleus of eukaryotic cells as part of post-transcriptional modification. However, RNU6-241P itself is a **processed pseudogene**—an inactive copy—originating from retrotransposition or duplication events, and is one among many similar pseudogenes found in vertebrate genomes[1][3]. These pseudogenes do not participate in spliceosome function, do not encode proteins, and have no established biological or disease-related activity. They have been used as molecular markers to study the dynamics of retrotransposition and genome evolution[3]. RNU6-241P does not function as a canonical bioactive target (receptor, enzyme, transporter, etc.), nor is it known to interact with drugs or act as a diagnostic biomarker. The presence of numerous U6 pseudogenes in the genome reflects the evolutionary importance of the spliceosome but does not confer any known therapeutic or diagnostic function on the pseudogenes themselves[1][3][5].

Other names
RNU6-241PRNA, U6 small nuclear 241, pseudogene
02

Mechanism of action

None known; not a direct drug target

03

Biological functions

Pseudogenes generally have no canonical biological function, but can sometimes play regulatory roles in gene expression or participate in ceRNA networks; for RNU6-241P, no validated biological function is described
04

Disease associations

There is no evidence for a direct role of RNU6-241P in disease; pseudogenes in general can occasionally play roles in cancer and other diseases by acting as decoys or competitive endogenous RNAs (ceRNAs), but this has not been established for RNU6-241P
05

Safety considerations

None (not a drug target; pseudogenes generally do not present therapeutic safety issues)
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, U6 small nuclear 241, pseudogene (RNU6-241P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 241, pseudogene (RNU6-241P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call